R. N. Gonzalez
Cornell University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by R. N. Gonzalez.
Journal of Dairy Science | 2008
D. Bar; Loren W. Tauer; Gary J. Bennett; R. N. Gonzalez; J.A. Hertl; Y.H. Schukken; H. F. Schulte; F.L. Welcome; Y.T. Gröhn
The objective of this study was to estimate the cost of generic clinical mastitis (CM) in high-yielding dairy cows given optimal decisions concerning handling of CM cases. A specially structured optimization and simulation model that included a detailed representation of repeated episodes of CM was used to study the effects of various factors on the cost of CM. The basic scenario was based on data from 5 large herds in New York State. In the basic scenario, 92% of the CM cases were recommended to be treated. The average cost of CM per cow and year in these herds was
Veterinary Microbiology | 2009
Y.H. Schukken; R. N. Gonzalez; Linda L. Tikofsky; H. F. Schulte; Carlos Santisteban; F.L. Welcome; Gary J. Bennett; Michael J. Zurakowski; Ruth N. Zadoks
71. The average cost of a CM case was
Veterinary Clinics of North America-food Animal Practice | 2003
R. N. Gonzalez; David J. Wilson
179. It was composed of
Journal of Dairy Science | 2010
J.A. Hertl; Y.T. Gröhn; J.D. G. Leach; D. Bar; Gary J. Bennett; R. N. Gonzalez; B.J. Rauch; F.L. Welcome; Loren W. Tauer; Y.H. Schukken
115 because of milk yield losses,
Veterinary Clinics of North America-food Animal Practice | 1993
P. M. Sears; R. N. Gonzalez; David J. Wilson; Hong R. Han
14 because of increased mortality, and
Journal of Dairy Science | 2011
E. Cha; D. Bar; J.A. Hertl; Loren W. Tauer; Gary J. Bennett; R. N. Gonzalez; Y.H. Schukken; F.L. Welcome; Yrjö T. Gröhn
50 because of treatment-associated costs. The estimated cost of CM was highly dependent on cow traits: it was highest (
Journal of Food Protection | 2004
Ruth N. Zadoks; R. N. Gonzalez; Kathryn J. Boor; Y.H. Schukken
403) in cows with high expected future net returns (e.g., young, high-milk-yielding cows), and was lowest (
Journal of Dairy Science | 2008
D. Bar; Y.T. Gröhn; Gary J. Bennett; R. N. Gonzalez; J.A. Hertl; H. F. Schulte; Loren W. Tauer; F.L. Welcome; Y.H. Schukken
3) in cows that were recommended to be culled for reasons other than mastitis. The cost per case of CM was 18% higher with a 20% increase in milk price and 17% lower with a 20% decrease in milk price. The cost per case of CM was affected little by a 20% change in replacement cost or pregnancy rate. Changes in CM incidence, however, resulted from changes in these factors, thus affecting whole-farm profitability. The detailed results obtained from this insemination and replacement optimization model can assist farmers in making CM treatment decisions.
American Journal of Veterinary Research | 2009
Hussni O. Mohammed; Korana Stipetić; Patrick L. McDonough; R. N. Gonzalez; D.V. Nydam; Edward R. Atwill
In this paper, we analyzed a very large field data set on intramammary infections (IMI) and the associated somatic cell count (SCC) in dairy cows. The objective of the study was to analyze the impact of coagulase-negative staphylococci (CNS) IMI on cow SCC, both mean and variability, and on the potential of these infections to have a major impact on the bulk milk SCC (BMSCC). Data and milk samples for bacterial culture were collected by Quality Milk Production Services (QMPS) between 1992 and March of 2007. The QMPS program services dairy farms in New York State and other states in the Northeastern USA and operates in conjunction with Cornell University. Only records from cows where SCC and milk production data were available, and where only one organism was isolated from bacterial cultures of milk samples (or where culture was negative) were used for this analysis. A total of 352,614 records from 4200 whole herd mastitis screening sampling qualified for this study. Within herds an average of 15% (S.D. 12%) of cows sampled were infected with CNS, ranging between 0 and 100%. Average within herd prevalence of cows with a CNS IMI and an SCC over 200,000 cells/ml was 2% (S.D. 4%) with a minimum of 0% and a maximum of 50%. Results of linear mixed models showed three distinct populations of IMI statuses: negative cultures with the lowest SCC; CNS and Corynebacterium bovis with a moderate increase in SCC, and Streptococcus agalactiae, Streptococcus spp. and Staphylococcus aureus showing an important increase in SCC. Surprisingly, milk production was slightly but significantly higher in CNS infected cows compared to culture-negative cows, whereas it was strongly reduced in cows with a major pathogen IMI. The percentage contribution of CNS infections to the BMSCC was 17.9% in herds with a BMSCC less than 200,000 cells/ml. This value decreased to 11.9 and 7.9% in herds with bulk milk SCC between 200,000 and 400,000 and over 400,000 cells/ml, respectively. We concluded that very few herds with milk quality problems would have an important increase in BMSCC that could be mostly attributed to CNS infections. On the other hand, in herds with low BMSCC, CNS infections may be an important contributor to the total number of somatic cells in the bulk milk.
Journal of Dairy Science | 2008
David J. Wilson; Y.T. Gröhn; Gary J. Bennett; R. N. Gonzalez; Y.H. Schukken; J. Spatz
Mycoplasmal bovine mastitis is potentially a highly contagious disease that can cause severe economic problems in affected herds. The purchase of replacement heifers and cows are frequently the origin of mycoplasmal mastitis outbreaks in previously Mycoplasma-free herds. Purchased cows and heifers should be quarantined and tested for mycoplasmal mastitis before admission to the regular herd. Detection of Mycoplasma-infected cows by culture of milk is straightforward, although there are problems of sensitivity for its detection in milk samples that are inherent to the nature of the disease and laboratory procedures. After detection of infected cows, the best way to protect the herd is to culture all cows in the herd, cows with clinical mastitis, and all heifers and cows after calving and before entering the milking herd. Control of mycoplasmal mastitis requires test and culling from the herd of Mycoplasma-positive cows if possible. When a large number of cows are infected, strict segregation with adequate management is an option; however, animals in this group should never re-enter the Mycoplama-free herd. The functioning of the milking equipment and milking procedures should be evaluated carefully and any flaws corrected. There is no treatment for mycoplasmal mastitis, and vaccination has not proven to be efficacious to prevent, decrease the incidence, or ameliorate the clinical signs of mycoplasmal mastitis. Waste milk should not be fed to calves without pasteurization. M bovis may cause several other pathologies in animals of different ages on a farm, including pneumonia, arthritis, and ear infections. The survival of mycoplasmas in different farm microenvironments needs to be further investigated for its impact on the epidemiology of the disease.